Knogle 200 Nasal Spray 60Md 6Ml belongs to groups of medications called hypocalcemic agents, used to treat high blood calcium levels (hypercalcemia) and Postmenopausal Osteoporosis. Besides this, it can also help treat complications of Paget's disease. Hypercalcemia is a condition in which the calcium level in your blood is above normal. Postmenopausal osteoporosis is a medical condition that causes thinning and weakening of the bones during/after a menopausal period. Paget’s disease is a chronic disease of bone that disrupts the replacement of old bone tissue with new bone tissue, resulting in the new bone that is abnormally shaped, weak and brittle.

Knogle 200 Nasal Spray 60Md 6Ml contains Calcitonin. It reduces the activity of osteoclasts, which are the cells responsible for bone breakdown. When bone is broken down, the calcium in the bone is released into the bloodstream. As a result, calcitonin's suppression of osteoclasts limits the quantity of calcium released into the blood. Furthermore, it can reduce calcium resorption in the kidneys, resulting in decreased blood calcium levels.

Knogle 200 Nasal Spray 60Md 6Ml will be administered by a qualified healthcare professional. Kindly do not self-administer. In some cases, Knogle 200 Nasal Spray 60Md 6Ml can cause side effects, including injection site reactions, nausea with or without vomiting and flushing of the face or hands. Most of these side effects of Knogle 200 Nasal Spray 60Md 6Ml do not require medical attention and gradually resolve over time. However, if these side effects persist longer, please consult your doctor.

Before taking the Knogle 200 Nasal Spray 60Md 6Ml, let your doctor know about all your medical conditions, sensitivities, and all medications you are using. And also, inform your doctor if you are pregnant, planning to become pregnant, or breastfeeding. Knogle 200 Nasal Spray 60Md 6Ml should not be given to children as safety and efficacy have not been established.

Knogle 200 Nasal Spray 60Md 6Ml contains calcitonin, which belongs to groups of medications called hypocalcemic agents and is used to treat high blood calcium levels (hypercalcemia) and Postmenopausal Osteoporosis. On the other hand, it can also help people with Paget's disease of bone. Knogle 200 Nasal Spray 60Md 6Ml reduces the activity of osteoclasts, which are the cells responsible for bone breakdown. When bone is broken down, the calcium in the bone is released into the bloodstream. As a result, calcitonin's suppression of osteoclasts limits the quantity of calcium released into the blood. Furthermore, it can reduce calcium resorption in the kidneys, decreasing blood calcium levels.

Before taking the Knogle 200 Nasal Spray 60Md 6Ml, let your doctor know about all your medical conditions, sensitivities, and all medications you are using. And also, inform your doctor if you are pregnant, planning to become pregnant, or breastfeeding. Knogle 200 Nasal Spray 60Md 6Ml should not be given to children as safety and efficacy have not been established. In rare situations, Knogle 200 Nasal Spray 60Md 6Ml may cause major hypersensitivity reactions in individuals receiving Miacalcin injection, including bronchospasm, inflammation of the tongue or throat and anaphylactic shock. If you encounter any of these symptoms, contact your doctor right once.

• Certain diagnostic tests, like blood tests, measure the calcitonin level in your blood, and bone density scans are used to check bone mineral density (BMD).
• Clinical monitoring of serum electrolyte concentrations is recommended.